unloved, page-3

Whatsup,

There is nothing to do with PAB. It is the mentality of traders nowadays.

People trying to make quick money by trading in and out multiple times. Look at FGE recently, I admit that I do trade (both FGE and PAB) but this is the current trend in the stock market. No one willing to hold a stock for longer than a week and I bet you that half of people who buy and sell PAB does not understand what a monoclonal antibody is. What they care is will SM6 cure cancer !!!!

The clinical trail development is extremely costly and intense and difficult and long process, the good thing is that we have big pharma like Amgen provide the essential funding to us.

36% patient response positively to SM6. that is a BIG number

DYOR